Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aviceda Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aviceda Therapeutics

Aviceda Therapeutics

Aviceda Therapeutics: A late-stage biotech firm developing glyco-immune disease drugs, with a focus on eye diseases, fibrosis, neurology, and oncology.

Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize the treatment of glyco-immune diseases, Aviceda Therapeutics is a late-stage, pre-clinical biotech company. The organization leverages the power of glycobiology to create next-generation immunomodulators aimed at addressing chronic non-resolving inflammation and the innate immune system. Aviceda’s product pipeline includes treatments for eye diseases, fibrosis, neurology, and oncology, utilizing highly selective ligands for maximum specificity towards target immune cells and diseases.

Aviceda Therapeutics boasts a team of notable experts in biotechnology and immunology, alongside significant backing from prominent investors in the biotech sector. The company has achieved key milestones in pre-clinical development, positioning itself as a leader in glyco-therapeutics. Through its innovative approach and cutting-edge technologies, Aviceda aims to make a profound impact on the treatment landscape for chronic inflammatory and immune-related conditions.

Aviceda Therapeutics - Similar Companies

Abvc Biopharma logo

Abvc Biopharma

Avexegen Therapeutics logo

Avexegen Therapeutics

Avidity Biosciences logo

Avidity Biosciences

aviditybio.com

Invea Therapeutics logo

Invea Therapeutics

inveatx.com

Avotres logo

Avotres

avotres.com

Therini Bio logo

Therini Bio

therinibio.com

Avalo Therapeutics logo

Avalo Therapeutics

avalotx.com

Aristea Therapeutics logo

Aristea Therapeutics

Indalo Therapeutics logo

Indalo Therapeutics

Elgia Therapeutics logo

Elgia Therapeutics

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Attovia Therapeutics logo

Attovia Therapeutics

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

Alivio Therapeutics logo

Alivio Therapeutics

Aditxt logo

Aditxt

aditxt.com

Aviceda Therapeutics - Quick Facts

Who are Aviceda Therapeutics' competitors?

Companies similar to Aviceda Therapeutics include Abvc Biopharma, Avexegen Therapeutics, Avidity Biosciences and Invea Therapeutics.

When was Aviceda Therapeutics founded?

Aviceda Therapeutics was founded in 2018.

When was Aviceda Therapeutics' last funding round?

Aviceda Therapeutics' most recent funding round was for $15.6M (USD) in May 2023.

How much has Aviceda Therapeutics raised to-date?

As of May 19, 2023, Aviceda Therapeutics has raised a total of $69.3M (USD).

How many employees does Aviceda Therapeutics have?

Aviceda Therapeutics has 17 employees as of Feb 5, 2024.

Aviceda Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotech Drugs
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified